129 related articles for article (PubMed ID: 17974464)
41. Acute megakaryoblastic leukemia in a child with the MLL-AF4 fusion gene.
Takita J; Motomura A; Koh K; Ida K; Taki T; Hayashi Y; Igarashi T
Eur J Haematol; 2009 Aug; 83(2):149-53. PubMed ID: 19459927
[TBL] [Abstract][Full Text] [Related]
42. Long-term remission with imatinib mesylate in Philadelphia chromosome-positive AML presenting as primary extramedullary myeloid sarcoma.
Ahmed MS; Kroft SH; Davis NB; King DM; Cheng YC
Leuk Res; 2008 Sep; 32(9):1476-9. PubMed ID: 18308388
[TBL] [Abstract][Full Text] [Related]
43. Neutrophilic leukemoid reaction as the presenting feature of de novo and therapy-related acute leukemias.
Olipitz W; Strunk D; Beham-Schmid C; Sill H
Acta Haematol; 2004; 111(4):233-4. PubMed ID: 15153719
[No Abstract] [Full Text] [Related]
44. Is there an entity of chemically induced BCR-ABL-positive chronic myelogenous leukemia?
Lichtman MA
Oncologist; 2008 Jun; 13(6):645-54. PubMed ID: 18586919
[TBL] [Abstract][Full Text] [Related]
45. Isolated myelosarcoma development in an adolescent chronic myeloid leukemia patient with t(9;22)(q34;q11.2), +8, +14, +21, and der(1)(p36).
Oren H; Yilmaz S; Sercan Z; Demircioğlu F; Yüksel E; Irken G
Cancer Genet Cytogenet; 2008 Apr; 182(1):43-5. PubMed ID: 18328950
[TBL] [Abstract][Full Text] [Related]
46. Coexistence of meningeal infiltration and multiple lymphadenopathy as the initial presentation of de novo adult acute megakaryoblastic leukemia.
Wang W; Li X; Hou J; Zhou J
Leuk Res; 2011 May; 35(5):e50-2. PubMed ID: 21255836
[No Abstract] [Full Text] [Related]
47. BCR-ABL messenger RNA levels continue to decline in patients with chronic phase chronic myeloid leukemia treated with imatinib for more than 5 years and approximately half of all first-line treated patients have stable undetectable BCR-ABL using strict sensitivity criteria.
Branford S; Seymour JF; Grigg A; Arthur C; Rudzki Z; Lynch K; Hughes T
Clin Cancer Res; 2007 Dec; 13(23):7080-5. PubMed ID: 18056186
[TBL] [Abstract][Full Text] [Related]
48. Acute megakaryocytic leukaemia (AMKL)-like disease in a cynomolgus monkey (Macaca fascicularis).
Okabayash S; Ohno C; Yasutomi Y
J Comp Pathol; 2009; 140(2-3):212-6. PubMed ID: 19159898
[TBL] [Abstract][Full Text] [Related]
49. Case report and literature review: a rare patient with chronic myeloid leukemia and chronic lymphocytic leukemia.
Bhagavathi S; Borromeo V; Desai H; Crisan D
Ann Clin Lab Sci; 2008; 38(4):405-9. PubMed ID: 18988937
[TBL] [Abstract][Full Text] [Related]
50. Osteonecrosis complicating chronic myeloid leukaemia.
Joseph DE; Egesie OJ; Alao OO
Niger J Med; 2006; 15(3):337-9. PubMed ID: 17111774
[TBL] [Abstract][Full Text] [Related]
51. Two cases of extramedullary myeloid tumor in patients with continuous remission of acute myeloblastic leukemia.
Slavcheva V; Lukanov T; Tzvetkov N
J BUON; 2008; 13(4):589-92. PubMed ID: 19145688
[TBL] [Abstract][Full Text] [Related]
52. Imaging findings of upper abdominal involvement by acute megakaryoblastic leukaemia.
Amemiya S; Akahane M; Takita J; Igarashi T; Ohtomo K
Pediatr Radiol; 2008 Apr; 38(4):457-61. PubMed ID: 18172635
[TBL] [Abstract][Full Text] [Related]
53. A case of acute basophilic leukemia arising from chronic myelogenous leukemia with development of t(7;8)(q32;q13).
Pidala J; Pinilla-Ibarz J; Cualing HD
Cancer Genet Cytogenet; 2008 Apr; 182(1):46-9. PubMed ID: 18328951
[TBL] [Abstract][Full Text] [Related]
54. Postmortem diagnosis of acute megakaryocytic leukemia. Usefulness of immunohistochemistry and tissue hemogram.
Umezawa A; Yamada T; Ogawa Y; Kuramochi S; Watanabe Y
Acta Pathol Jpn; 1990 Sep; 40(9):693-8. PubMed ID: 2260477
[TBL] [Abstract][Full Text] [Related]
55. Flow cytometric assay of phosphotyrosine levels in Bcr-Abl-positive chronic myelogenous leukemias: a potential prognostic marker.
Sun X; Li J; Chen J; Li D; Chen L; Xu W; Yang Y; Wu Y; Jiang P; Xie W
Ann Hematol; 2009 Jan; 88(1):29-36. PubMed ID: 18696070
[TBL] [Abstract][Full Text] [Related]
56. Childhood acute megakaryoblastic leukemia with internalization of hemic cells.
Shimizu H; Ui T; Sasaki K; Kawai S; Kaneko Y; Fujimoto T
Am J Pediatr Hematol Oncol; 1990; 12(4):477-9. PubMed ID: 2285130
[TBL] [Abstract][Full Text] [Related]
57. Chronic myelogenous leukemia showing biphenotypic blast crisis followed by lineage switch to B lymphoblastic leukemia.
Oh SH; Park TS; Kim HR; Lee JY; Kim JH; Shin JH; Lee JN
Leuk Res; 2009 Nov; 33(11):e195-8. PubMed ID: 19446879
[TBL] [Abstract][Full Text] [Related]
58. [Major molecular response to imatinib in a patient with acute mixed lineage leukemia expressing a novel BCR/ABL transcript].
Liu HX; Cao XY; Tong CR; Wu T; Wang T; Fan QZ; Wu P; Zhang X; Cai P; Zhu P
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):220-3. PubMed ID: 19552835
[TBL] [Abstract][Full Text] [Related]
59. Different kinetic patterns of BCR-ABL transcript levels in imatinib-treated chronic myeloid leukemia patients after achieving complete cytogenetic response.
Qin YZ; Liu YR; Zhu HH; Li JL; Ruan GR; Zhang Y; Jiang Q; Jiang H; Li LD; Chang Y; Huang XJ; Chen SS
Int J Lab Hematol; 2008 Aug; 30(4):317-23. PubMed ID: 18665830
[TBL] [Abstract][Full Text] [Related]
60. [Therapy of chronic myeloid leukemia. Uncommon view of the modern approaches].
Mayer J; Zácková D; Klamová H; Doubek M
Cas Lek Cesk; 2008; 147(4):206-10. PubMed ID: 18578373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
